“A Four-Way, Cross-Over Design, Randomized, Double-Blinded, Placebo-&Active-Controlled Study for the Evaluation of the Effect of a Supratherapeutic Dose of Sofpironium Bromide Gel, 15% Applied Topically on the QT QTc Intervals in Adult Healthy Volunteers”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s109. https://doi.org/10.25251/skin.4.supp.109.